Hoth Therapeutics Joins NVIDIA Connect to Boost AI Research
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical firm targeted on creating breakthrough therapeutics at this time introduced that it has been formally accepted into the NVIDIA Connect Program, a world initiative supporting modern software program and expertise firms working with superior computing and AI platforms. Acceptance into the NVIDIA Connect Program gives Hoth Therapeutics with…
